摘要
目的:讨论机器人辅助腹腔镜根治性肾切除术在治疗T2期肾癌的手术方法及临床经验。方法:回顾性分析2013年3月~2016年5月,应用达芬奇机器人辅助腹腔镜技术完成的26例根治性肾切除术,且根据术后病理分期为T2期肿瘤患者的临床资料。结果:26例手术全部经腹途径完成,均顺利完成。手术时间110~300 min,平均177.9 min;术中出血量40~900ml,平均222.6ml;胃肠功能恢复时间1~6d,平均3.2d;引流管拔除时间1~12d,平均4.3d;术后住院时间3~19d,平均7.1d。肿瘤最大直径7.5~17.0cm,平均11.2cm。术后随访时间3~12个月,所有患者无局部复发及远处转移。结论:机器人辅助腹腔镜根治性肾切除术治疗T2期肾癌是潜在可行的,更多的临床手术经验、长期的随访结果将对其效果进行评估,进一步大量的随机对照研究有利于这一技术的推广及应用。
Objective:To summarize the experience of robotic radical nephrectomy(RRN)in the treatment of T2 renal cell carcinoma.Methods:A retrospective analysis was performed,the clinical data of 26 patients with T2 renal cell carcinoma who underwent RRN were collected from March 2013 to May 2016.Results:All 26 cases were completed successfully,and no one was converted to open surgery.The average operative time was 177.9 min(ranged from 110-300min)with estimated blood loss of 222.6mL(ranged from 40-900mL).The mean orally allowed time was 3.2day(ranged from 1-6day),The average post-operative drainage time 4.3day(ranged from 1-12day)and the mean hospital stay was 7.1day(ranged from 3-19day).The mean tumor size was 11.2cm(ranged from 7.5-17.0cm).With a short-term follow-up period(3-12 months),no local residual lesions and disease progression.Conclusions:The RRN is potentially feasible and safe for the treatment of T2 renal cell carcinoma.operational experience and the results of long-term follow-up visit will be studied to estimate the operation method.Forward randomized controlled trials will be beneficial to a wider application of the technology.
出处
《微创泌尿外科杂志》
2017年第1期36-38,共3页
Journal of Minimally Invasive Urology
基金
国家高技术研究发展计划(863计划)资助课题(2014AA020607)
